Clinical care of adult Turner syndrome - New aspects

Pediatric Endocrinology Reviews

Volumn 9, Issue SUPPL. 2, 2012, Pages 739-749

  Trolle, Christian ^a   Mortensen, Kristian Havmand ^a   Hjerrild, Britta E ^a   Cleemann, Line ^b   Gravholt, Claus Højbjerg ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b HILLERØD HOSPITAL   (Denmark)

Author keywords

Adult height; Androgens; Cardiovascular diseases; Epidemiology; Estrogens; Genes; Glucose metabolism; Growth; Growth hormone; Hypertension; Insulin resistance; Ischemic heart disease; Liver function; Morbidity; Mortality; Puberty; Thyroid function; Turner syndrome

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; FOLLITROPIN; GLUCOSE; GROWTH HORMONE; LUTEINIZING HORMONE; METHYLTESTOSTERONE; OXANDROLONE; SEX HORMONE;

ADULTHOOD; AORTA COARCTATION; AORTA DISSECTION; ATHEROSCLEROSIS; BODY HEIGHT; CELIAC DISEASE; CHILDHOOD CANCER; CONFERENCE PAPER; DIABETES MELLITUS; FEMALE INFERTILITY; GLUCOSE BLOOD LEVEL; GONADOBLASTOMA; HORMONAL THERAPY; HUMAN; HYPERTENSION; HYPOGONADISM; HYPOPLASTIC LEFT HEART SYNDROME; HYPOTHYROIDISM; MONOTHERAPY; MORBIDITY; MORTALITY; NONALCOHOLIC FATTY LIVER; OBESITY; OOCYTE DONATION; OSTEOPOROSIS; OVARY INSUFFICIENCY; PREVALENCE; PRIMARY MEDICAL CARE; PROGNOSIS; PUBERTY; QT PROLONGATION; TURNER SYNDROME;

ADULT; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FEMALE; HUMANS; LIVER DISEASES; OSTEOPOROSIS; PRIMARY OVARIAN INSUFFICIENCY; THYROID DISEASES; TRANSITION TO ADULT CARE; TURNER SYNDROME;

EID: 84864572464     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (92)

1. Nielsen J, Wohlert M. Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum Genet 1991;87:81-83
2. Rivkees SA, Hager K, Hosono S, Wise A, Li P, Rinder HM, Gruen JR. A highly sensitive, high-throughput assay for the detection of turner syndrome. J Clin Endocrinol Metab 2011;96:699-705
3. Gravholt CH, Juul S, Naeraa RW, Hansen J. Morbidity in Turner syndrome. J Clin Epidemiol 1998;51:147-158 (Pubitemid 28066141)
4. Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA. Cancer incidence in women with Turner syndrome in Britain: a national cohort study. Lancet Oncol 2008;9:239-246
5. Gravholt CH, Fedder J, Naeraa RW, Muller J. Occurrence of gonadoblastoma in females with Turner syndrome and Y chromosome material: a population study. J Clin Endocrinol Metab 2000;85:3199-3202
6. Larsen T, Gravholt CH, Tillebeck A, Larsen H, Jensen MB, Nielsen J, Friedrich U. Parental origin of the X chromosome, X chromosome mosaicism and screening for "hidden" Y chromsome in 45,X Turner syndrome ascertained cytogenetically. Clin Genet 1995;48:6-11
7. Mazzanti L, Cicognani A, Baldazzi L, Bergamaschi R, Scarano E, Strocchi S, Nicoletti A, Mencarelli F, Pittalis M, Forabosco A, Cacciari E. Gonadoblastoma in Turner syndrome and Y-chromosome-derived material. Am J Med Genet A 2005;135:150-154. (Pubitemid 40769964)
8. Canto P, Kofman-Alfaro S, Jimenez AL, Soderlund D, Barron C, Reyes E, Mendez JP, Zenteno JC. Gonadoblastoma in Turner syndrome patients with nonmosaic 45,X karyotype and Y chromosome sequences. Cancer Genet Cytogenet 2004;150:70-72 (Pubitemid 38369251)
9. Swerdlow AJ, Hermon C, Jacobs PA, Alberman E, Beral V, Daker M, Fordyce A, Youings S. Mortality and cancer incidence in persons with numerical sex chromosome abnormalities: a cohort study. Ann Hum Genet 2001;65:177-188 (Pubitemid 32452119)
10. Stochholm K, Juul S, Juel K, Naeraa R.W., Gravholt CH. Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab 2006;91:3897-3902 (Pubitemid 44536861)
11. Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA. Mortality in women with turner syndrome in Great Britain: a national cohort study. J Clin Endocrinol Metab 2008;93:4735-4742
12. Ho VB, Bakalov VK, Cooley M, Van PL, Hood MN, Burklow TR, Bondy CA. Major vascular anomalies in Turner syndrome: prevalence and magnetic resonance angiographic features. Circulation 2004;110:1694-1700 (Pubitemid 39297995)
13. Mortensen KH, Hjerrild BE, Andersen NH, Sørensen KE, Hørlyck A, Pedersen EM, Lundorf E, Christiansen JS, Gravholt CH. Abnormalities of the major intra-thoracic arteries in Turner syndrome: a magnetic resonance imaging study. Cardiol Young 2010;20:191-200
14. Sybert VP. Cardiovascular malformations and complications in Turner syndrome. Pediatrics 1998;101:11-17
15. Nathwani NC, Unwin R, Brook CG, Hindmarsh PC. Blood pressure and Turner syndrome. Clin Endocrinol (Oxf) 2000;52:363-370 (Pubitemid 30169693)
16. Gravholt CH, Naeraa RW, Nyholm B, Gerdes U, Christiansen E, Schmitz O, Christiansen JS. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner syndrome: the impact of sex hormone replacement. Diabetes Care 1998;21:1062-1070 (Pubitemid 28368509)
17. Gravholt CH, Hansen KW, Erlandsen M, Ebbehoj E, Christiansen JS. Nocturnal hypertension and impaired sympathovagal tone in Turner syndrome. J Hypertens 2006;24:353-360 (Pubitemid 43348249)
18. Ostberg JE, Donald AE, Halcox JP, Storry C, McCarthy C, Conway GS. Vasculopathy in Turner syndrome: arterial dilatation and intimai thickening without endothelial dysfunction. J Clin Endocrinol Metab 2005;90:5161-5166 (Pubitemid 41262269)
19. Bakalov VK, Cooley MM, Quon MJ, Luo ML, Yanovski JA, Nelson LM, Sullivan G, Bondy CA. Impaired insulin secretion in the Turner metabolic syndrome. J Clin Endocrinol Metab 2004;89:3516-3520 (Pubitemid 38951929)
20. Gravholt CH, Naeraa RW, Fisker S, Christiansen JS. Body composition and physical fitness are major determinants of the growth hormone-IGF axis aberrations in adult Turner syndrome, with important modulations by treatment with 17-beta-estradiol. J Clin Endocrinol Metab 1997;82:2570-2577 (Pubitemid 27337875)
21. Elsheikh M, Hodgson HJ, Wass JA, Conway GS. Hormone replacement therapy may improve hepatic function in women with Turner's syndrome. Clin Endocrinol (Oxf) 2001;55:227-231
22. Gravholt CH, Poulsen HE, Ott P, Christiansen JS, Vilstrup H. Quantitative liver functions in Turner syndrome with and without hormone replacement therapy. Eur J Endocrinol 2007;156:679-686 (Pubitemid 46952538)
23. Cooley M, Bakalov V, Bondy CA. Lipid profiles in women with 45,X vs 46,XX primary ovarian failure. JAMA 2003;290:2127-2128 (Pubitemid 37432971)
24. Gravholt CH, Klausen IC, Weeke J, Christiansen JS. Lp(a) and lipids in adult Turner's syndrome: impact of treatment with 17beta-estradiol and norethisterone. Atherosclerosis 2000;150:201-208
25. Gravholt CH, Mortensen KH, Andersen NH, Ibsen L, Ingerslev J, Hjerrild BE. Coagulation and fibrinolytic disturbances are related to carotid intima thickness and arterial blood pressure in Turner syndrome. Clin Endocrinol (Oxf) 2011;10-2265
26. Gravholt CH, Hjerrild BE, Mosekilde L, Hansen TK, Rasmussen LM, Frystyk J, Flyvbjerg A, Christiansen JS. Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules. Eur J Endocrinol 2006;155:583-592 (Pubitemid 44608432)
27. Elsheikh M, Casadei B, Conway GS, Wass JA. Hypertension is a major risk factor for aortic root dilatation in women with Turner's syndrome. Clin Endocrinol (Oxf) 2001;54:69-73 (Pubitemid 32158707)
28. Gravholt CH, Landin-Wilhelmsen K, Stochholm K, Hjerrild BE, Ledet T, Djurhuus CB, Sylven L, Baandrup U, Kristensen BO, Christiansen JS. Clinical and epidemiological description of aortic dissection in Turner's syndrome. Cardiol Young 2006;16:430-436 (Pubitemid 44596617)
29. Matura LA, Ho VB, Rosing DR, Bondy CA. Aortic dilatation and dissection in Turner syndrome. Circulation 2007;116:1663-1670 (Pubitemid 47542238)
30. Hjerrild BE, Mortensen KH, Sørensen KE, Pedersen EM, Andersen NH, Lundorf E, Hansen KW, Hørlyck A, Hager A, Christiansen JS, Gravholt CH. Thoracic aortopathy in Turner syndrome and the influence of bicuspid aortic valves and blood pressure - a MRI study. J Cardiovasc Magn Res 2010;12:12
31. Cleemann L, Mortensen KH, Holm K, Smedegaard H, Skouby SO, Wieslander SB, Leffers AM, Leth-Espensen P, Pedersen EM, Gravholt CH. Aortic dimensions in girls and young women with Turner syndrome: a magnetic resonance imaging study. Pediatr Cardiol 2010;31:497-504
32. Mortensen KH, Hjerrild BE, Stochholm K, Andersen NH, Sorensen KE, Lundorf E, Horlyck A, Pedersen EM, Christiansen JS, Gravholt CH. Dilation of the ascending aorta in Turner syndrome - a prospective cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 2011;13:24
33. Baguet JP, Douchin S, Pierre H, Rossignol AM, Bost M, Mallion JM. Structural and functional abnormalities of large arteries in the Turner syndrome. Heart 2005;91:1442-1446 (Pubitemid 41531823)
34. Andersen NH, Hjerrild BE, Sørensen K, Pedersen EM, Stochholm K, Gormsen LC, Hørlyck A, Christiansen JS, Gravholt CH. Subclinical left ventricle dysfunction in normotensive women with Turner's syndrome. Heart 2006;92:1516-1517 (Pubitemid 44578858)
35. Bondy CA, Van PL, Bakalov VK, Sachdev V, Malone CA, Ho VB, Rosing DR. Prolongation of the cardiac QTc interval in Turner syndrome. Medicine (Baltimore) 2006;85:75-81
36. van der Schouw YT, van der GY, Steyerberg EW, Eijkemans JC, Banga JD. Age at menopause as a risk factor for cardiovascular mortality. Lancet 1996;347:714-718
37. Turgeon JL, Carr MC, Maki PM, Mendelsohn ME, Wise PM. Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: insights from basic science and clinical studies. Endocr Rev 2006;27:575-605 (Pubitemid 44582052)
38. Lopez L, Arheart KL, Colan SD, Stein NS, Lopez-Mitnik G, Lin AE, Reller MD, Ventura R, Silberbach M. Turner syndrome is an independent risk factor for aortic dilation in the young. Pediatrics 2008;121:1622-1627
39. Ostberg JE, Brookes JA, McCarthy C, Halcox J, Conway GS. A comparison of echocardiography and magnetic resonance imaging in cardiovascular screening of adults with Turner syndrome. J Clin Endocrinol Metab 2004;89:5966-5971 (Pubitemid 39628401)
40. Pasquino AM, Passeri F, Pucarelli I, Segni M, Municchi G. Spontaneous pubertal development in Turner's syndrome. Italian Study Group for Turner's Syndrome. J Clin Endocrinol Metab 1997;82:1810-1813 (Pubitemid 127495191)
41. Hreinsson JG, Otala M, Fridstrom M, Borgstrom B, Rasmussen C, Lundqvist M, Tuuri T, Simberg N, Mikkola M, Dunkel L, Hovatta O. Follicles are found in the ovaries of adolescent girls with Turner's syndrome. J Clin Endocrinol Metab 2002;87:3618-3623 (Pubitemid 34879504)
42. Gravholt CH, Naeraa RW, Andersson AM, Christiansen JS, Skakkebaek NE. Inhibin A and B in adolescents and young adults with Turner's syndrome and no sign of spontaneous puberty. Hum Reprod 2002;17:2049-2053
43. Hagen CP, Aksglaede L, Sorensen K, Main KM, Boas M, Cleemann L, Holm K, Gravholt CH, Andersson AM, Pedersen AT, Petersen JH, Linneberg A, Kjaergaard S, Juul A. Serum Levels of Anti-Mullerian Hormone as a Marker of Ovarian Function in 926 Healthy Females from Birth to Adulthood and in 172 Turner Syndrome Patients. J Clin Endocrinol Metab 2010;95:5003-5010
44. Prossnitz ER, Barton M. The G-protein-coupled estrogen receptor GPER in health and disease. Nat Rev Endocrinol 2011;10
45. Elsheikh M, Bird R, Casadei B, Conway GS, Wass JA. The effect of hormone replacement therapy on cardiovascular hemodynamics in women with Turner's syndrome. J Clin Endocrinol Metab 2000;85:614-618 (Pubitemid 32273642)
46. Cleemann L, Hjerrild BE, Lauridsen AL, Heickendorff L, Christiansen JS, Mosekilde L, Gravholt CH. Long-term hormone replacement therapy preserves bone mineral density in Turner syndrome. Eur J Endocrinol 2009;161:251-257
47. Gravholt CH, Naeraa RW, Nyholm B, Gerdes LU, Christiansen E, Schmitz O, Christiansen JS. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement. Diabetes Care 1998c;21:1062-1070 (Pubitemid 28368509)
48. Gravholt CH, Svenstrup B, Bennett P, Christiansen JS. Low androgen levels in adult Turner syndrome: influence of female sex hormones and growth hormone status. Clin Endocrinol Oxf 1999;50:791-800 (Pubitemid 29284514)
49. Taboada M, Santen R, Lima J, Hossain J, Singh R, Klein KO, Mauras N. Pharmacokinetics and Pharmacodynamics of Oral and Transdermal 17{beta} Estradiol in Girls with Turner Syndrome. J Clin Endocrinol Metab 2011;
50. Guttmann H, Weiner Z, Nikolski E, Ish-Shalom S, Itskovitz-Eldor J, Aviram M, Reisner S, Hochberg Z. Choosing an oestrogen replacement therapy in young adult women with Turner syndrome. Clin Endocrinol (Oxf) 2001;54:159-164 (Pubitemid 32193516)
51. Zuckerman-Levin N, Frolova-Bishara T, Militianu D, Levin M, Aharon-Peretz J, Hochberg Z. Androgen replacement therapy in Turner syndrome: a pilot study. J Clin Endocrinol Metab 2009;94:4820-4827
52. Ostberg JE, Storry C, Donald AE, Attar MJ, Halcox JP, Conway GS. A dose-response study of hormone replacement in young hypogonadal women: effects on intima media thickness and metabolism. Clin Endocrinol (Oxf) 2007;66:557-564 (Pubitemid 46434939)
53. Piippo S, Lenko H, Kainulainen P, Sipila I. Use of percutaneous estrogen gel for induction of puberty in girls with Turner syndrome. J Clin Endocrinol Metab 2004;89:3241-3247 (Pubitemid 38951888)
54. Davenport ML. Moving toward an understanding of hormone replacement therapy in adolescent girls: looking through the lens of Turner syndrome. Ann N Y Acad Sci 2008;1135:126-37:126-137
55. Eastell R. Role of oestrogen in the regulation of bone turnover at the menarche. J Endocrinol 2005;185:223-234 (Pubitemid 40691789)
56. Rosenfield RL, Devine N, Hunold JJ, Mauras N, Moshang T, Jr., Root AW. Salutary effects of combining early very low-dose systemic estradiol with growth hormone therapy in girls with Turner syndrome. J Clin Endocrinol Metab 2005;90:6424-6430 (Pubitemid 41759295)
57. Van Pareren YK, de Muinck Keizer-Schrama SM, Stijnen T, Sas TC, Drop SL. Effect of discontinuation of long-term growth hormone treatment on carbohydrate metabolism and risk factors for cardiovascular disease in girls with Turner syndrome. J Clin Endocrinol Metab 2002;87:5442-5448 (Pubitemid 36034341)
58. Rovet J. Turner syndrome: a review of genetic and hormonal influences on neuropsychological functioning. Neuropsychol Dev Cogn C Child Neuropsychol 2004;10:262-279 (Pubitemid 40095939)
59. Ross J, Roeltgen D, Zinn A. Cognition and the sex chromosomes: studies in Turner syndrome. Horm Res 2006;65:47-56 (Pubitemid 43177318)
60. Ross JL, Roeltgen D, Feuillan P, Kushner H, Cutler-GB J. Effects of estrogen on nonverbal processing speed and motor function in girls with Turner's syndrome. J Clin Endocrinol Metab 1998;83:3198-3204 (Pubitemid 28500957)
61. Sylven L, Magnusson C, Hagenfeldt K, von Schoultz B. Life with Turner's syndrome - a psychosocial report from 22 middle-aged women. Acta Endocrinol Copenh 1993;129:188-194 (Pubitemid 23295678)
62. Chevalier N, Letur H, Lelannou D, Ohl J, Cornet D, Chalas-Boissonnas C, Frydman R, Catteau-Jonard S, Greck-Chassain T, Papaxanthos-Roche A, Dulucq MC, Couet ML, Cedrin-Durnerin I, Pouly JL, Fenichel P. Materno-Fetal Cardiovascular Complications in Turner Syndrome after Oocyte Donation: Insufficient Prepregnancy Screening and Pregnancy Follow-Up Are Associated with Poor Outcome. J Clin Endocrinol Metab 2011;96:260-267
63. Bondy CA. Care of girls and women with Turner syndrome: a guideline of the Turner syndrome study group. J Clin Endocrinol Metab 2007;92:10-25 (Pubitemid 46067503)
64. Foudila T, Soderstrom A, V, Hovatta O. Turner's syndrome and pregnancies after oocyte donation. Hum Reprod 1999;14:532-535 (Pubitemid 29097413)
65. Apter D, Lenko HL, Perheentupa J, Soderholm A, Vihko R. Subnormal pubertal increases of serum androgens in Turner's syndrome. Horm Res 1982;16:164-173 (Pubitemid 12123270)
66. Snajderova M, Mardesic T, Lebl J, Gerzova H, Teslik L, Zapletalova J. The uterine length in women with Turner syndrome reflects the postmenarcheal daily estrogen dose. Horm Res 2003;60:198-204 (Pubitemid 37256067)
67. Mauras N, Shulman D, Hsiang HY, Balagopal P, Welch S. Metabolic effects of oral versus transdermal estrogen in growth hormone-treated girls with Turner syndrome. J Clin Endocrinol Metab 2007;92:4154-4160 (Pubitemid 350074725)
68. Khastgir G, Studd JW, Fox SW, Jones J, Alaghband-Zadeh J, Chow JW. A longitudinal study of the effect of subcutaneous estrogen replacement on bone in young women with Turner's syndrome. J Bone Miner Res 2003;18:925-932 (Pubitemid 37294978)
69. Nabhan ZM, Dimeglio LA, Qi R, Perkins SM, Eugster EA. Conjugated oral versus transdermal estrogen replacement in girls with Turner syndrome: a pilot comparative study. J Clin Endocrinol Metab 2009;94:2009-2014
70. Langrish JP, Mills NL, Bath LE, Warner P, Webb DJ, Kelnar CJ, Critchley HO, Newby DE, Wallace WH. Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure. Hypertension 2009;53:805-811
71. Crofton P, Evans N, Bath LE, Warner P, Whitehead TJ, Critchley HO, Kelnar CJ, Wallace WH. Physiological versus standard sex steroid replacement in young women with premature ovarian failure: effects on bone mass acquisition and turnover. Clin Endocrinol (Oxf) 2010
72. Sylven L, Hagenfeldt K, Brondum NK, von Schoultz B. Middle-aged women with Turner's syndrome. Medical status, hormonal treatment and social life. Acta Endocrinol 1991;125:359-365
73. Roulot D, Degott C, Chazouilleres O, Oberti F, Cales P, Carbonell N, Benferhat S, Bresson-Hadni S, Valla D. Vascular involvement of the liver in Turner's syndrome. Hepatology 2004;39:239-247 (Pubitemid 38461487)
74. Koulouri O, Ostberg J, Conway GS. Liver dysfunction in Turner's syndrome: prevalence, natural history and effect of exogenous oestrogen. Clin Endocrinol (Oxf) 2008;69:306-310 (Pubitemid 352009030)
75. Bonamico M, Pasquino AM, Mariani P, Danesi HM, Culasso F, Mazzanti L, Petri A, Bona G. Prevalence and clinical picture of celiac disease in Turner syndrome. J Clin Endocrinol Metab 2002;87:5495-5498 (Pubitemid 36034350)
76. Mortensen KH, Cleemann L, Hjerrild BE, Nexo E, Locht H, Jeppesen EM, Gravholt CH. Increased prevalence of autoimmunity in Turner syndrome-influence of age. Clin Exp Immunol 2009;156:205-210
77. Elsheikh M, Conway GS. The impact of obesity on cardiovascular risk factors in Turner's syndrome. Clin Endocrinol (Oxf) 1998;49:447-450 (Pubitemid 28475336)
78. Landin-Wilhelmsen K, Bryman I, Windh M, Wilhelmsen L. Osteoporosis and fractures in Turner syndrome-importance of growth promoting and oestrogen therapy. Clin Endocrinol (Oxf) 1999;51:497-502 (Pubitemid 29513318)
79. Caprio S, Boulware S, Diamond M, Sherwin RS, Carpenter TO, Rubin K, Amiel S, Press M, Tamborlane WV. Insulin resistance: an early metabolic defect of Turner's syndrome. J Clin Endocrinol Metab 1991;72:832-836 (Pubitemid 21921773)
80. Salgin B, Amin R, Yuen K, Williams RM, Murgatroyd P, Dunger DB. Insulin resistance is an intrinsic defect independent of fat mass in women with Turner's syndrome. Horm Res 2006;65:69-75 (Pubitemid 43289471)
81. Stoppoloni G, Prisco F, Alfano C, Iafusco D, Marrazzo G, Paolisso G. Characteristics of insulin resistance in Turner syndrome. Diabete Metab 1990;16:267-271 (Pubitemid 20333945)
82. Hjerrild BE, Holst JJ, Juhl CB, Christiansen JS, Schmitz O, Gravholt CH. Delayed beta-cell response and glucose intolerance in young women with Turner syndrome. BMC Endocr Disord 2011;11:6:6
83. Bakalov VK, Cheng C, Zhou J, Bondy CA. X-chromosome gene dosage and the risk of diabetes in Turner syndrome. J Clin Endocrinol Metab 2009;94:3289-3296
84. Sas T, Muinck Keizer-Schrama S, Aanstoot HJ, Stijnen T, Drop S. Carbohydrate metabolism during growth hormone treatment and after discontinuation of growth hormone treatment in girls with Turner syndrome treated with once or twice daily growth hormone injections. Clin Endocrinol (Oxf) 2000;52:741-747 (Pubitemid 30409267)
85. Gravholt CH, Vestergaard P, Hermann AP, Mosekilde L, Brixen K, Christiansen JS. Increased fracture rates in Turner's syndrome: a nationwide questionnaire survey. Clin Endocrinol (Oxf) 2003;59:89-96 (Pubitemid 36774113)
86. Ross JL, Long LM, Feuillan P, Cassorla F, Cutler GBJ. Normal bone density of the wrist and spine and increased wrist fractures in girls with Turner's syndrome. J Clin Endocrinol Metab 1991;73:355-359 (Pubitemid 21921881)
87. Bertelloni S, Cinquanta L, Baroncelli GI, Simi P, Rossi S, Saggese G. Volumetric bone mineral density in young women with Turner's syndrome treated with estrogens or estrogens plus growth hormone. Horm Res 2000;53:72-76
88. Carrascosa A, Gussinye M, Terradas P, Yeste D, Audi L, Vicens-Calvet E. Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients. J Bone Miner Res 2000;15:2005-2010
89. Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, van Teunenbroek A, Van Leeuwen WJ, Asarfi A, Van Rijn RR, Drop SL. Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose-response study. Pediatr Res 2001;50:417-422 (Pubitemid 32801969)
90. El Mansoury M, Bryman I, Berntorp K, Hanson C, Wilhelmsen L, Landin-Wilhelmsen K. Hypothyroidism is common in turner syndrome: results of a five-year follow-up. J Clin Endocrinol Metab 2005;90:2131-2135 (Pubitemid 40586251)
91. Jorgensen KT, Rostgaard K, Bache I, Biggar RJ, Nielsen NM, Tommerup N, Frisch M. Autoimmune diseases in women with Turner's Syndrome. Arthritis Rheum 2010;62:658-666
92. Freriks K, Timmermans J, Beerendonk CC, Verhaak CM, Netea-Maier RT, Otten BJ, Braat DD, Smeets DF, Kunst DH, Hermus AR, Timmers HJ. Standardized Multidisciplinary Evaluation Yields Significant Previously Undiagnosed Morbidity in Adult Women with Turner Syndrome. J Clin Endocrinol Metab 2011